tetano
Editor, Senior Moderator
mBio
. 2022 Aug 16;e0106021.
doi: 10.1128/mbio.01060-21. Online ahead of print.
The New SARS-CoV-2 Variants and Their Epidemiological Impact in Mexico
Rodrigo García-López[SUP] #[/SUP][SUP] 1 [/SUP], Estibalitz Laresgoiti-Servitje[SUP] #[/SUP][SUP] 2 [/SUP], Roselyn Lemus-Martin[SUP] #[/SUP][SUP] 3 [/SUP], Alejandro Sanchez-Flores[SUP] #[/SUP][SUP] 1 [/SUP], Carlos Sanders-Velez[SUP] #[/SUP][SUP] 4 [/SUP]
Affiliations
Abstract
The COVID-19 disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus started its deadly journey into a global pandemic in Wuhan, China, in December 2019, where it was first isolated. Subsequently, multiple variants of the virus have been identified worldwide. In this review, we discuss the overall landscape of the pandemic in Mexico, including its most prevalent variants, their surveillance at a genomic level, and how they impacted the epidemiology of the disease. We also evaluate the heterologous vaccination in Mexico and how it may have influenced group immunity and helped mitigate the pandemic. Finally, we present an integrated view that could help us to understand the pandemic and serve as an example of the situation in Latin America.
Keywords: COVID-19 pandemic; SARS-CoV-2 variants; genomic vigilance; vaccination.
. 2022 Aug 16;e0106021.
doi: 10.1128/mbio.01060-21. Online ahead of print.
The New SARS-CoV-2 Variants and Their Epidemiological Impact in Mexico
Rodrigo García-López[SUP] #[/SUP][SUP] 1 [/SUP], Estibalitz Laresgoiti-Servitje[SUP] #[/SUP][SUP] 2 [/SUP], Roselyn Lemus-Martin[SUP] #[/SUP][SUP] 3 [/SUP], Alejandro Sanchez-Flores[SUP] #[/SUP][SUP] 1 [/SUP], Carlos Sanders-Velez[SUP] #[/SUP][SUP] 4 [/SUP]
Affiliations
- PMID: 35972143
- DOI: 10.1128/mbio.01060-21
Abstract
The COVID-19 disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus started its deadly journey into a global pandemic in Wuhan, China, in December 2019, where it was first isolated. Subsequently, multiple variants of the virus have been identified worldwide. In this review, we discuss the overall landscape of the pandemic in Mexico, including its most prevalent variants, their surveillance at a genomic level, and how they impacted the epidemiology of the disease. We also evaluate the heterologous vaccination in Mexico and how it may have influenced group immunity and helped mitigate the pandemic. Finally, we present an integrated view that could help us to understand the pandemic and serve as an example of the situation in Latin America.
Keywords: COVID-19 pandemic; SARS-CoV-2 variants; genomic vigilance; vaccination.